Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Largo | LGO | Nov 1, 2024 | 2.31 | -4.94 |
Larimar Therapeutics | LRMR | Nov 1, 2024 | 7.74 | -5.90 |
Las Vegas Sands | LVS | Nov 1, 2024 | 51.73 | -0.23 |
Laser Photonics | LASE | Nov 1, 2024 | 5.14 | -3.93 |
Latham Group | SWIM | Nov 1, 2024 | 6.47 | -0.46 |
Latin America Alphadex First Trust | FLN | Nov 1, 2024 | 16.63 | -2.12 |
Lattice Semiconductor | LSCC | Nov 1, 2024 | 52.27 | +3.18 |
Launch One Acquisition | LPAAU | Nov 1, 2024 | 10.01 | -0.10 |
Launch One Acquisition | LPAA | Nov 1, 2024 | 9.97 | 0.00 |
Launch Two Acquisition Units | LPBBU | Nov 1, 2024 | 9.97 | 0.00 |
Laureate Education | LAUR | Nov 1, 2024 | 16.90 | -1.63 |
LAVA Therapeutics | LVTX | Nov 1, 2024 | 1.90 | +4.97 |
Lavoro | LVRO | Nov 1, 2024 | 4.48 | +11.95 |
Lazard A | LAZ | Nov 1, 2024 | 53.31 | +0.60 |
Lazard Global Total Return and Income Fund | LGI | Nov 1, 2024 | 16.62 | -0.72 |
Lazydays | GORV | Nov 1, 2024 | 1.13 | -0.88 |
LCI Industries | LCII | Nov 1, 2024 | 112.58 | +1.17 |
LCNB | LCNB | Nov 1, 2024 | 16.06 | +2.36 |
Lead Real Estate ADR | LRE | Nov 1, 2024 | 1.97 | -14.34 |
Leafly | LFLY | Nov 1, 2024 | 1.72 | -1.15 |
Leap Therapeutics | LPTX | Nov 1, 2024 | 3.74 | 0.00 |
Lear | LEA | Nov 1, 2024 | 96.72 | +1.00 |
LeddarTech | LDTC | Nov 1, 2024 | 0.25 | -1.43 |
Lee Enterprises | LEE | Nov 1, 2024 | 18.05 | +0.84 |
Legacy Housing | LEGH | Nov 1, 2024 | 25.67 | +3.51 |
LegalZoom.com | LZ | Nov 1, 2024 | 7.25 | +0.97 |
Legato Merger III | LEGT | Nov 1, 2024 | 10.25 | -0.10 |
Legend Biotech ADR | LEGN | Nov 1, 2024 | 44.36 | -1.47 |
Legg Mason Low Volatility High Dividend ETF | LVHD | Nov 1, 2024 | 39.62 | -0.80 |
Leggett & Platt | LEG | Nov 1, 2024 | 12.02 | +0.17 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.